Literature DB >> 36057684

Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.

Ari Alex Ramos1,2,3, Noelia Galiano-Castillo4, Liana Machado5,6.   

Abstract

First-degree relatives of individuals with late-onset Alzheimer's disease (LOAD) are at increased risk for developing dementia, yet the associations between family history of LOAD and cognitive dysfunction remain unclear. In this quantitative review, we provide the first meta-analysis on the cognitive profile of unaffected first-degree blood relatives of LOAD-affected individuals compared to controls without a family history of LOAD. A systematic literature search was conducted in PsycINFO, PubMed /MEDLINE, and Scopus. We fitted a three-level structural equation modeling meta-analysis to control for non-independent effect sizes. Heterogeneity and risk of publication bias were also investigated. Thirty-four studies enabled us to estimate 218 effect sizes across several cognitive domains. Overall, first-degree relatives (n = 4,086, mean age = 57.40, SD = 4.71) showed significantly inferior cognitive performance (Hedges' g = -0.16; 95% CI, -0.25 to -0.08; p < .001) compared to controls (n = 2,388, mean age = 58.43, SD = 5.69). Specifically, controls outperformed first-degree relatives in language, visuospatial and verbal long-term memory, executive functions, verbal short-term memory, and verbal IQ. Among the first-degree relatives, APOE ɛ4 carriership was associated with more significant dysfunction in cognition (g = -0.24; 95% CI, -0.38 to -0.11; p < .001) compared to non-carriers (g = -0.14; 95% CI, -0.28 to -0.01; p = .04). Cognitive test type was significantly associated with between-group differences, accounting for 65% (R23 = .6499) of the effect size heterogeneity in the fitted regression model. No evidence of publication bias was found. The current findings provide support for mild but robust cognitive dysfunction in first-degree relatives of LOAD-affected individuals that appears to be moderated by cognitive domain, cognitive test type, and APOE ɛ4.
© 2022. The Author(s).

Entities:  

Keywords:  APOE ɛ4; Alzheimer disease; Cognitive dysfunction; Family history; Neuropsychological tests; Risk factors

Year:  2022        PMID: 36057684     DOI: 10.1007/s11065-022-09555-2

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   6.940


  76 in total

1.  Familial risk for Alzheimer's disease alters fMRI activation patterns.

Authors:  Susan Spear Bassett; David M Yousem; Catherine Cristinzio; Ivana Kusevic; Michael A Yassa; Brian S Caffo; Scott L Zeger
Journal:  Brain       Date:  2006-05       Impact factor: 13.501

Review 2.  The application of functional genomics to Alzheimer's disease.

Authors:  Ramón Cacabelos
Journal:  Pharmacogenomics       Date:  2003-09       Impact factor: 2.533

Review 3.  Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  Nat Rev Neurosci       Date:  2008-10       Impact factor: 34.870

4.  Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients.

Authors:  Carolina Abulafia; Leticia Fiorentini; David A Loewenstein; Rosie Curiel-Cid; Gustavo Sevlever; Charles B Nemeroff; Mirta F Villarreal; Daniel E Vigo; Salvador M Guinjoan
Journal:  J Psychiatr Res       Date:  2019-02-22       Impact factor: 4.791

5.  A diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer's disease: The adult children study.

Authors:  Andrew J Aschenbrenner; David A Balota; Brian A Gordon; Roger Ratcliff; John C Morris
Journal:  Neuropsychology       Date:  2016-02       Impact factor: 3.295

Review 6.  Aging, Senescence, and Dementia.

Authors:  Q Behfar; A Ramirez Zuniga; P V Martino-Adami
Journal:  J Prev Alzheimers Dis       Date:  2022

7.  Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

Authors:  Deborah Blacker; Hang Lee; Alona Muzikansky; Emily C Martin; Rudolph Tanzi; John J McArdle; Mark Moss; Marilyn Albert
Journal:  Arch Neurol       Date:  2007-06

8.  Decreased cognition in children with risk factors for Alzheimer's disease.

Authors:  Cinnamon S Bloss; Dean C Delis; David P Salmon; Mark W Bondi
Journal:  Biol Psychiatry       Date:  2008-08-22       Impact factor: 13.382

9.  Brain Structural and Amyloid Correlates of Recovery From Semantic Interference in Cognitively Normal Individuals With or Without Family History of Late-Onset Alzheimer's Disease.

Authors:  Carolina Abulafia; David Loewenstein; Rosie Curiel-Cid; Bárbara Duarte-Abritta; Stella M Sánchez; Daniel E Vigo; Mariana N Castro; Lucas J Drucaroff; Silvia Vázquez; Gustavo Sevlever; Charles B Nemeroff; Salvador M Guinjoan; Mirta F Villarreal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-10-11       Impact factor: 2.198

10.  Preventing the ends from justifying the means: withholding results to address publication bias in peer-review.

Authors:  Katherine S Button; Liz Bal; Anna Clark; Tim Shipley
Journal:  BMC Psychol       Date:  2016-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.